Compare IVDA & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVDA | GCTK |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | 32 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 3.0M |
| IPO Year | N/A | 2011 |
| Metric | IVDA | GCTK |
|---|---|---|
| Price | $0.28 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 391.6K | ★ 567.6K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.22 | $0.29 |
| 52 Week High | $2.58 | $15.90 |
| Indicator | IVDA | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 29.44 |
| Support Level | $0.27 | N/A |
| Resistance Level | $0.35 | $1.02 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 6.58 | 17.64 |
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.